Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Dry Age-Related Macular Degeneration AMD Companies

Dry age-related macular degeneration (dry AMD) is a common eye condition that can lead to vision loss, particularly in older adults. While there is no cure for dry AMD, several companies are actively involved in developing treatments and therapies to slow its progression and improve the quality of life for affected individuals.

Dry Age-Related Macular Degeneration Key Companies

*Disclaimer: List of key companies in no particular orderLatest Dry age-related macular degeneration Companies Update

July 2023: To make its worldwide organization as competitive as feasible, Santen Pharmaceutical Co. Ltd. has decided to sell its North American branded ophthalmic inventory to Visiox Pharma LLC and Harrow Health Inc. To manufacture, market, and sell OMLONTI®, an eye drop used to lower increased intraocular pressure (IOP) in people with glaucoma or ocular hypertension, Santen has reached an out-licensing agreement with Visiox Pharmaceuticals, Inc. According to the contract's provisions, Santen gives Visiox the only authority to manufacture and market OMLONTI® products in the United States. Santen is entitled to royalty payments on gross U.S. sales of OMLONTI® as well as sales milestone payments.

Sep 2023: XIIDRA® (lifitegrast ophthalmic solution) five percent, a non-steroid eye drops specifically approved to treat symptoms and signs of dry eye disease with a focus on inflammation associated with dry eye, as well as some other ophthalmology assets, have been acquired by Bausch + Lomb Corporation, a division of Bausch Health Companies. Following the terms of the contract, Bausch + Lomb acquired XIIDRA® and the other eye care assets from Novartis through an affiliate for up to $2.5 billion, including a cash payment of $1.75 billion upfront and potential milestone responsibilities of up to $750 million according to sales limits and pipeline commercialization. The closure of the transaction took place roughly concurrently with the issuing of the Notes and the completion of the Term Loan Facility.

List of Dry age-related macular degeneration Key companies in the market

Santen Pharmaceuticals Inc. (Japan)

Allergan plc (Ireland)

Bausch Health (Canada)

Alimera Science Inc. (US)

Phio Pharmaceuticals Corp (US)

Ocumension Therapeutics Co. Ltd (China)

Belite Bio Inc. (US)

Kubota Vision Inc. (US)

Iveric Bio (US)

Eyestem Research Pvt Ltd (India)

Dry Age-Related Macular Degeneration AMD Market Highlights:

Dry Age-Related Macular Degeneration AMD Market Size

Dry Age-Related Macular Degeneration AMD Market Trends

Dry Age-Related Macular Degeneration AMD Market Analysis

Dry Age-Related Macular Degeneration AMD Market Share

Dry Age-Related Macular Degeneration AMD Market Highlights:

Dry Age-Related Macular Degeneration AMD Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.